Biography:
Dr. Yonglei Liu joined the Experimental Research Center (Qingpu Hospital, Fudan University, Shanghai, China). She received her PhD degree in 2011 at Fudan University and she has received advanced training as a postdoctoral researcher in MD Anderson Cancer Center. Her research field is tumor biology.The main research focus is on the role of stem cells in the tumor microenvironment, including chemotherapy resistance, ferroptosis, and their effects on immune cells.
YWHAZ suppresses ferroptosis in cancer by modulating glutathione synthesis by HDAC2 lactylation